300
Participants
Start Date
June 6, 2018
Primary Completion Date
December 27, 2018
Study Completion Date
December 27, 2018
Bivalent influenza vaccine
A single dose of bivalent vaccine (10\^7±5 fluorescent focus unit of 2 cold-adapted, attenuated, temperature-sensitive, 6:2 reassortant influenza strain) will be administered as intranasal spray on Day 1.
Placebo
A single dose of placebo matched to bivalent influenza vaccine will be administered as intranasal spray on Day 1.
Research Site, Stockbridge
Research Site, Portland
Lead Sponsor
MedImmune LLC
INDUSTRY